Will cilostazol improve care for patients with intermittent claudication?

被引:0
|
作者
不详
机构
关键词
Human Immunodeficiency Virus Type; Clopidogrel; Peripheral Arterial Disease; Pentoxifylline; Cilostazol;
D O I
10.2165/00042310-199914010-00001
中图分类号
学科分类号
摘要
[No abstract available]
引用
收藏
页码:1 / 5
页数:4
相关论文
共 50 条
  • [21] PRINCIPLES IN CARE OF PATIENTS WITH INTERMITTENT CLAUDICATION
    BROULIKOVA, A
    SBORNIK LEKARSKY, 1989, 91 (2-3): : 57 - 62
  • [22] Comparative effects of cilostazol and other therapies for intermittent claudication
    Dawson, DL
    AMERICAN JOURNAL OF CARDIOLOGY, 2001, 87 (12A): : 19D - 27D
  • [23] ASSOCIATION OF CILOSTAZOL USE WITH LONG TERM VASCULAR OUTCOMES IN PATIENTS WITH INTERMITTENT CLAUDICATION
    Muncan, Brandon
    Abboud, Alan
    Tassiopoulos, Apostolos K.
    Kalogeropoulos, Andreas P.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 1767 - 1767
  • [24] Measuring treatment effects of cilostazol on clinical trial endpoints in patients with intermittent claudication
    Smith, JAM
    CLINICAL CARDIOLOGY, 2002, 25 (03) : 91 - 94
  • [25] Effect of the novel antiplatelet agent cilostazol on plasma lipoproteins in patients with intermittent claudication
    Elam, MB
    Heckman, J
    Crouse, JR
    Hunninghake, DB
    Herd, JA
    Davidson, M
    Gordon, IL
    Bortey, EB
    Forbes, WP
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (12) : 1942 - 1947
  • [26] A pooled analysis of the durability and predictors of treatment response of cilostazol in patients with intermittent claudication
    Pande, Reena L.
    Hiatt, William R.
    Zhang, Peter
    Hittel, Norbert
    Creager, Mark A.
    VASCULAR MEDICINE, 2010, 15 (03) : 181 - 188
  • [27] CILOSTAZOL TREATMENT IN PATIENTS SUFFERING FROM INTERMITTENT CLAUDICATION ASSOCIATED WITH BUERGER'S DISEASE
    Kaya, E.
    Doganci, S.
    Arslan, G.
    Karabacak, K.
    Bolcal, C.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 163 : S18 - S18
  • [28] Differential effects of cilostazol and pentoxifylline on vascular endothelial growth factor in patients with intermittent claudication
    Lee, TM
    Su, SF
    Tsai, CH
    Lee, YT
    Wang, SS
    CLINICAL SCIENCE, 2001, 101 (03) : 305 - 311
  • [29] Cost-utility of cilostazol for the treatment of intermittent claudication in Scotland
    Ratcliffe, A
    VALUE IN HEALTH, 2005, 8 (06) : A113 - A114
  • [30] Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease
    Money, SR
    Herd, JA
    Isaacsohn, JL
    Davidson, M
    Cutler, B
    Heckman, J
    Forbes, WP
    JOURNAL OF VASCULAR SURGERY, 1998, 27 (02) : 267 - 274